Emma Barrow

Summary

Country: UK

Publications

  1. doi request reprint Cost analysis of biomarker testing for mismatch repair deficiency in node-positive colorectal cancer
    E Barrow
    Department of General Surgery, Manchester Royal Infirmary, St Mary s Hospital, Manchester, UK
    Br J Surg 95:868-75. 2008
  2. doi request reprint Cancer risk in Lynch Syndrome
    Emma Barrow
    Department of General Surgery, University of Manchester and Central Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Oxford Road, Manchester, UK
    Fam Cancer 12:229-40. 2013
  3. doi request reprint Successful radiofrequency ablation of an anterior abdominal wall desmoid in familial adenomatous polyposis
    E Barrow
    Department of General Surgery, University of Manchester and Central Manchester and Manchester Children s University Hospitals NHS Trust, Manchester, UK
    Colorectal Dis 15:e160-3. 2013
  4. doi request reprint Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations
    E Barrow
    Department of General Surgery, Manchester Royal Infirmary, Manchester, UK
    Clin Genet 74:233-42. 2008
  5. doi request reprint Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
    E Barrow
    Department of General Surgery, Manchester Royal Infirmary, Manchester, UK
    Clin Genet 75:141-9. 2009
  6. doi request reprint Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome
    Emma Barrow
    Department of General Surgery, Manchester Royal Infirmary, Manchester, M13 9WL, UK
    Histopathology 56:331-44. 2010
  7. doi request reprint A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome
    Emma Barrow
    Department of General Surgery, Manchester Royal Infirmary, Oxford Road, Manchester, UK
    J Clin Pathol 64:208-14. 2011

Detail Information

Publications7

  1. doi request reprint Cost analysis of biomarker testing for mismatch repair deficiency in node-positive colorectal cancer
    E Barrow
    Department of General Surgery, Manchester Royal Infirmary, St Mary s Hospital, Manchester, UK
    Br J Surg 95:868-75. 2008
    ..The evidence suggests that patients with tumours caused by defective DNA MMR do not benefit from 5-fluorouracil (5-FU)-based chemotherapy...
  2. doi request reprint Cancer risk in Lynch Syndrome
    Emma Barrow
    Department of General Surgery, University of Manchester and Central Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Oxford Road, Manchester, UK
    Fam Cancer 12:229-40. 2013
    ..Accurate estimation of cancer risk for mutation carriers is essential for counselling, and establishing appropriate screening guidelines. This study reviews the current data on cancer risk, and emerging risk reduction strategies. ..
  3. doi request reprint Successful radiofrequency ablation of an anterior abdominal wall desmoid in familial adenomatous polyposis
    E Barrow
    Department of General Surgery, University of Manchester and Central Manchester and Manchester Children s University Hospitals NHS Trust, Manchester, UK
    Colorectal Dis 15:e160-3. 2013
    ..There are few effective treatment strategies. This report describes the use of radiofrequency ablation to debulk and palliate an abdominal wall desmoid tumour in FAP...
  4. doi request reprint Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations
    E Barrow
    Department of General Surgery, Manchester Royal Infirmary, Manchester, UK
    Clin Genet 74:233-42. 2008
    ..Current colonoscopic screening guidelines are appropriate...
  5. doi request reprint Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
    E Barrow
    Department of General Surgery, Manchester Royal Infirmary, Manchester, UK
    Clin Genet 75:141-9. 2009
    ..0003). Gastric cancer risk in those born after 1935 does not justify surveillance. These penetrance estimates have been corrected for ascertainment bias and are appropriate for those referred to a high-risk clinic...
  6. doi request reprint Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome
    Emma Barrow
    Department of General Surgery, Manchester Royal Infirmary, Manchester, M13 9WL, UK
    Histopathology 56:331-44. 2010
    ..To assess semiquantitative immunohistochemistry as used in the diagnosis of Lynch syndrome...
  7. doi request reprint A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome
    Emma Barrow
    Department of General Surgery, Manchester Royal Infirmary, Oxford Road, Manchester, UK
    J Clin Pathol 64:208-14. 2011
    ..Quantum dots (QDs) are novel fluorescent labels that enable quantitative multiplex staining. This study compared their use with quantitative 3,3'-diaminobenzidine (DAB) IHC for the diagnosis of Lynch Syndrome...